Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Experimental and Applied Biomedical Research (EABR)
Volume 23 (2022): Issue 3 (September 2022)
Open Access
Treatment Options in Patients Suffering from Hemolytic-Uremic Syndrome: The Serbian Military Medical Academy Experience
Jelena Tadic
Jelena Tadic
,
Mirjana Mijuskovic
Mirjana Mijuskovic
,
Marijana Petrovic
Marijana Petrovic
,
Katarina Obrencevic
Katarina Obrencevic
,
Brankica Terzic
Brankica Terzic
,
Violeta Rabrenovic
Violeta Rabrenovic
,
Neven Vavic
Neven Vavic
and
Đoko Maksic
Đoko Maksic
| Sep 20, 2022
Experimental and Applied Biomedical Research (EABR)
Volume 23 (2022): Issue 3 (September 2022)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Sep 20, 2022
Page range:
237 - 242
Received:
Jun 27, 2019
Accepted:
Sep 16, 2019
DOI:
https://doi.org/10.2478/sjecr-2019-0060
Keywords
Hemolytic-uremic syndrome
,
atypical hemolytic-uremic syndrome
,
C3
,
corticosteroids
,
plasmapheresi
© 2022 Jelena Tadic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.